The Association of the British Pharmaceutical Industry (ABPI) has named its new medical, innovation and research director as Dr Bina Rawal, who will join the trade body’s top team in October.
Rawal will be the senior medical spokesperson for the research-based UK pharmaceutical industry to government, the media and professional organisations and will be responsible for advancing the productivity of the innovation process in the UK to build the country’s position in the global industry.
Rawal joins the ABPI from the Wellcome Trust where in her role as head of clinical development within the Technology Transfer Division (TTD) she has been responsible for oversight and governance of the clinical pipeline. Prior to joining the Wellcome Trust, she held senior roles at Roche and GlaxoWellcome R&D.
